| Ms Debra Lynn Autry, LVN | |
|
6222 N Lamar Blvd, Austin, TX 78752-4004 | |
| (512) 472-4357 | |
| (512) 703-1390 |
| Full Name | Ms Debra Lynn Autry |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 6222 N Lamar Blvd, Austin, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194199604 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 137953 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Debra Lynn Autry, LVN 913 Washburn Dr, Leander, TX 78641-8360 Ph: (512) 466-3320 | Ms Debra Lynn Autry, LVN 6222 N Lamar Blvd, Austin, TX 78752-4004 Ph: (512) 472-4357 |
News Archive
NIH researchers have "identified two previously unknown steps in the spread of the malaria parasite in the bloodstream" and found a way to interfere with one stage of the process, which could lead to the development of new malaria drugs, United Press International reports (6/10). The study was published online in Current Biology, according to an NIH press release (6/10).
Hospital patients with alcohol use disorders are at an increased risk of developing healthcare-associated infections, which affect 1.7 million patients annually in the United States. HAIs are infections that patients acquire during their hospitalization and that were not present at the time of admission to the hospital.
Described as a hotspot of botanical diversity, there are more than 20,000 indigenous plant species in South Africa. Several thousand of them are used by traditional healers every day in that country for treating a range of problems from the common cold to serious diseases such as AIDS.
Bruker announces that it has acquired Luxendo, a privately held spin-off of the European Molecular Biology Laboratory (EMBL) that develops and manufactures proprietary light-sheet fluorescence microscopy instruments.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced top-line results from the 4 mg/kg cohort and additional results from the 2 mg/kg cohort in a completed clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 7 days ago
Larissa Dyan Kirk, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1631 E 2nd St, Austin, TX 78702 Phone: 512-455-7787 | |
Christen Kavanaugh Schulte, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1430 Collier St, Austin, TX 78704 Phone: 512-445-7787 Fax: 512-440-4059 | |
Kimeca Gray, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 56 East Ave, Austin, TX 78701 Phone: 512-703-1365 | |
Edward Clark, LVN, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 6600 E Ben White Blvd, Austin, TX 78741 Phone: 512-804-3740 | |
Vickie Elaine Carrington, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1430 Collier St, Austin, TX 78704 Phone: 512-445-7787 Fax: 512-440-4059 | |
Joshua Hairell, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1631 E 2nd St Ste A, Austin, TX 78702 Phone: 512-804-3380 Fax: 512-472-5857 | |
Juan Alberto Bastida, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1434 Sir Thopas Trl, Austin, TX 78748 Phone: 512-424-9282 |